Katrina Snow: Non-Invasive Fetal Blood Group Genotyping Is Coming to Ontario
Katrina Snow, Transfusion Safety Officer at North York General Hospital, shared a post on LinkedIn:
“Did you know that up to 40% of RhD-negative pregnancies are with fetuses who are also RhD-negative?
Very soon, non-invasive fetal blood group genotyping will be available in Ontario, which is a non-invasive way to determine the RhD status (and in some cases other red cell antigens) of the fetus.
For patients this means personalized care that can reduce their exposure to a blood product.
For healthcare this means optimization of a limited resource (RhIG).
BORN Ontario will also collect data that will support QI and evaluation.
Provincial wide implementation means there will be equity in access to this testing.
Exciting times!
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 10:23Kalyan Roy: Could Alzheimer’s-Related Proteins Be Transmitted Through Blood Transfusion?
-
Sep 9, 2026, 07:31Fateema Capery: The State of Hemophilia Care in Mauritius and What Comes Next
-
Sep 9, 2026, 07:11Building a Stronger Future for Hemophilia Care in Bangladesh – World Federation of Hemophilia
-
Sep 9, 2026, 07:05Nael Ismail: Gene and Cell Therapy Are Transforming the Treatment of Human Genetic Diseases
-
Sep 9, 2026, 06:59Suswapna Singh Rawat: The Role of Platelets in Heart Disease and Antiplatelet Therapy
-
Sep 9, 2026, 06:39Chaza Alaji: How Hemophilia Became a Disease of Precision Medicine
-
Sep 9, 2026, 05:52Faheema Hasan: New ASH 2026 Guidelines Redefine Initial and Second-Line ITP Therapy
-
Sep 9, 2026, 05:43Thomas Pincez: Clonal Hematopoiesis Linked to Increased Risk of Autoimmune Hemolytic Anemia
-
Sep 9, 2026, 05:33Marianne Yee: Sickle Cell Disease and the Human Side of Medical Research